Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Guoqiang Wang
Nanjing Medical University - Wuxi Mental Health Center
Wuxi, Jiangsu Province 214151
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
46
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy, Safety, and Tolerability of Ansofaxine (Ly03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo Controlled, Dose-Finding, Phase 2 Clinical Trial
Number of pages: 29
Posted: 27 Jul 2021
Weifeng Mi
,
Fude Yang
,
Huafang Li
,
Xiufeng Xu
,
Lehua Li
,
Qingrong Tan
, Guoqiang Wang,
Kerang Zhang
,
Feng Tian
,
Jiong Luo
,
Jielai Xia
,
Kai Yuan
,
Lin Lu
,
Jiahui Deng
,
Jingwei Tian
and
Hongyan Zhang
Peking University, Peking University - Beijing HuiLongGuan Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Mental Health Center, Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Central South University - Second Xiangya Hospital, Government of the People's Republic of China - Department of Psychiatry, Nanjing Medical University - Wuxi Mental Health Center, Shanxi Medical University, Shanxi Medical University, Capital Medical University, Government of the People's Republic of China - Air Force Medical University, Peking University, Peking University - School of Public Health, Peking University, Yantai University - Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong and Peking University - NHC Key Laboratory of Mental Health
Downloads
46
(1,121,190)
View PDF
Download
Abstract:
Feedback